Valérie Aurillac-Lavignolle

Author

Also Known As

A. Colombo, V Aurillac‐Lavignolle, V. Aurillac-Lavignolle, VALERIE AURILLAC‐LAVIGNOLLE, Valerie Aurillac-Lavignolle, Valérie Aurillac-Lavignolle

Publications

729

Citations

H-Index

Concepts

All Affiliations

Inserm Bordeaux Population Health Hôpital Cardiologique du Haut-Lévêque Université de Bordeaux Centre Hospitalier Universitaire de Bordeaux

About

Valérie Aurillac-Lavignolle is an author at Inserm specializing in medicine, hiv, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	249
2	Public Health	2	2	63
3	Epidemiology	2	2	63
4	Immunology	1	1	34
5	Molecular Biology	1	1	56

Valérie Aurillac-Lavignolle

Publications

723

Citations

H-Index

Page 1

	Year	Citations
Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint Paul Khairy, Shinsuke Miyazaki, Valérie Aurillac-Lavignolle, Circulation Arrhythmia and Electrophysiology	2014	298
Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients<sup>*</sup> P. Mercié, Rodolphe Thiébaut, Valérie Aurillac-Lavignolle, HIV Medicine	2005	98
Endocardial Ablation to Eliminate Epicardial Arrhythmia Substrate in Scar-Related Ventricular Tachycardia Yuki Komatsu, Matthew Daly, Frédéric Sacher, Journal of the American College of Cardiology Endocardial AblationStructural Heart DiseaseScar-related Ventricular TachycardiaMedicineElectrophysiology	2014	96
Resistance Mutations in Subtype C HIV Type 1 Isolates from Indian Patients of Mumbai Receiving NRTIs Plus NNRTIs and Experiencing a Treatment Failure: Resistance to AR Alaka Deshpande, Valérie Jauvin, Noël Magnin, AIDS Research and Human Retroviruses Indian PatientsAntimicrobial Resistance GeneReverse GeneticsGeneticsReverse Transcriptase	2007	56
Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999–2004 Rodolphe Thiébaut, Valérie Aurillac-Lavignolle, Fabrice Bonnet, AIDS Vascular DiseaseMedian ImtThrombosisAtherosclerosis ProgressionHuman Retrovirus	2005	44
Quantitation of HIV-1 RNA in dried blood and plasma spots Sandrine Reigadas, Marie-Hélène Schrive, Valérie Aurillac-Lavignolle, Journal of Virological Methods Hiv-1 RnaViral PersistenceHuman RetrovirusImmunologyAntiviral Response	2009	34
Pravastatin in HIV-Infected Patients Treated with Protease Inhibitors: A Placebo-Controlled Randomized Study Fabrice Bonnet, Valérie Aurillac-Lavignolle, Dominique Breilh, HIV Clinical Trials	2007	27
Primary Resistance to Enfuvirtide (T20) in recently HIV-1 Infected, Antiretroviral-Naive Patients from the ANRS Aquitaine Cohort Olivia Peuchant, Sophie Capdepont, Jean‐Marie Ragnaud, Antiviral Therapy	2007	27
Impact of Substrate‐Based Ablation of Ventricular Tachycardia on Cardiac Mortality in Patients With Implantable Cardioverter‐Defibrillators Yuki Komatsu, Philippe Maury, Frédéric Sacher, Journal of Cardiovascular Electrophysiology	2015	24
Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients Stéphanie Badiou, Rodolphe Thiébaut, Valérie Aurillac-Lavignolle, Journal of Infection Vascular DiseaseCardiovascular DiseaseDyslipidemiaHivPublic Health	2008	19

Page 1